Rockley Photonics Expands Application Range for Biomarker Sensing Tech

Rockley Photonics has expanded the range of possible applications for its noninvasive biomarker sensing technology into new segments of the medical technology field. The company has signed strategic partnerships with two of what it says are the top-10 largest medical equipment and device manufacturers. Rockley did not identify the companies but said the two have a combined history of more than 200 years in the industry and represent more than $40 billion of revenue in the medical equipment market.

The partnerships will focus on evaluating and incorporating the next generation of noninvasive biomarker sensing in medical equipment and devices in various form factors for different parts of the body, and for different medical facilities, such as hospitals and clinics. Rockley expects that these partnerships will help advance potential use cases of real-time, noninvasive biomarker sensing in mobile devices for outpatient monitoring.

“These new applications and partnerships represent a very exciting opportunity for Rockley,” said Andrew Rickman, chief executive officer and founder of Rockley Photonics. “We believe that extending our technology into a wider variety of devices for both consumers and medtech will bring us one step closer to our vision of giving people better insights into their health and well-being.”

Rockley’s recently revealed “clinic-on-the-wrist” sensing platform has enabled device manufacturers to integrate more comprehensive noninvasive biomarker measurements in their products. Rockley’s proprietary photonics-based laser technology expands the range of biomarkers that can be detected and measured by current LED-based sensors. These new measurement capabilities could transform digital health care by providing real-time insights about a variety of health conditions and enabling early detection of multiple disease states.

Rockley is currently conducting human studies to refine the performance of its end-to-end sensing solution. Once these improvements are completed, Rockley believes that its cloud and artificial intelligence infrastructure can enable additional capabilities for the fast-growing digital health domain and generate real-time health insights for both patients and health care providers.